/
•
•
Detailed stories on technology startups, business and economic current affairs.
The online drugs and medical services startup made some costly acquisitions in a bid to pull off an IPO at a high valuation. That plan may be coming unstuck.

On Monday, Reuters reported that online drugs and medical services startup PharmEasy was looking to raise $200 million. What was disturbing was that the company was prepared to do it at a lower valuation than it last raised money at.
That PharmEasy would want to raise $200 million was first reported in The Economic Times in May, when the company was in talks with Goldman Sachs to raise a debt of Rs 2,700 crore (about $340 million). The Reuters report said PharmEasy was open to offering a 15% or even 25% discount to last year's $5.1 billion valuation.
Clearly, PharmEasy’s …